Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Net Margin (2020 - 2025)

Biofrontera has reported Net Margin over the past 6 years, most recently at 32.98% for Q4 2025.

  • Quarterly results put Net Margin at 32.98% for Q4 2025, up 4410.0% from a year ago — trailing twelve months through Dec 2025 was 25.26% (up 2232.0% YoY), and the annual figure for FY2025 was 25.26%, up 2232.0%.
  • Net Margin for Q4 2025 was 32.98% at Biofrontera, up from 95.15% in the prior quarter.
  • Over the last five years, Net Margin for BFRIW hit a ceiling of 57.03% in Q1 2022 and a floor of 369.45% in Q3 2021.
  • Median Net Margin over the past 5 years was 60.95% (2021), compared with a mean of 69.23%.
  • Biggest five-year swings in Net Margin: tumbled -27766bps in 2021 and later skyrocketed 31008bps in 2022.
  • Biofrontera's Net Margin stood at 158.21% in 2021, then skyrocketed by 83bps to 27.45% in 2022, then skyrocketed by 221bps to 33.28% in 2023, then crashed by -133bps to 11.12% in 2024, then surged by 397bps to 32.98% in 2025.
  • The last three reported values for Net Margin were 32.98% (Q4 2025), 95.15% (Q3 2025), and 58.96% (Q2 2025) per Business Quant data.